Celldex Therapeutics faces a flurry of analyst revisions, with Cantor Fitzgerald and Canaccord Genuity trimming targets to 61 and 60 while maintaining overweight/buy ratings, and Morgan Stanley lowering its target to 40, reflecting mixed sentiment. Meanwhile, firms like Guggenheim and Wells Fargo have raised targets to around 100 and 54 respectively, indicating a broad range of views on the stock’s near-term prospects as it trades in the mid-30s.

Finance· Jul 22, 2026

Facts from Wikidata (CC0). Image by CG via Wikimedia Commons (CC BY-SA 4.0).

Canaccord Financial

Canadian financial company

4members1here now

Ask Genius Site

Site Journal

Feed Discussions About

Sort by

Content type

Latest Canaccord Financial news and discussion

Sort by

Content type

Canaccord Financial· Finance · 7 sources · Jul 22, 2026Story

Analysts Trim Celldex Price Targets, Shares Fall

Finance· Jul 22, 2026

Facts from Wikidata (CC0). Image by CG via Wikimedia Commons (CC BY-SA 4.0).

Canaccord Financial across IJR

Ask Genius by OpenServe about Canaccord Financial Create in Studio Build a game Watch videos

About Canaccord Financial

Canaccord Genuity Group Inc. is an investment banking and financial services company that specializes in wealth management and brokerage in capital markets. It is one of the largest independent investment dealers in Canada. The firm focuses on growth companies, with operations in 10 countries. Canaccord Genuity, the international capital markets division, is based in Canada, with offices in the US, the UK, Europe, Asia, and Australia.

members

here now

Headquarters: Toronto
Inception: 1950

Coverage spread L0 / C100 / R0

Everything about Canaccord Financial →

Live room · 1 here

Be the first in the room — members see you arrive.

Join the room

Canaccord Financial across IJR

Ask Genius by OpenServe about Canaccord Financial Create in Studio Build a game Watch videos